Healthcare (Prescription Drugs)

HB 1280 requires pharmacists, pharmacy technicians, and pharmacy technician trainees in Pennsylvania to complete annual medication error prevention training. The training covers key topics like medication categories, overdose management, proper storage, and the "six principles" of medication administration (correct drug, dose, person, time, method, and documentation). Participants must score at least 80% on an exam and demonstrate knowledge of medication names, purposes, side effects, and special instructions to receive certification. New pharmacists licensed in Pennsylvania for less than five years must complete this training twice yearly until they meet the five-year threshold.

SB 190 establishes Pennsylvania's Pharmaceutical Transparency Review Board to address high-cost prescription drug affordability. The Board, composed of appointed experts with strict conflict-of-interest rules, reviews prescription drugs and develops recommendations for residents, government agencies, health plans, and other stakeholders. It requires pharmaceutical manufacturers (those setting drug prices) to provide pricing data and mandates public meetings and transparency in the review process. The bill also creates a dedicated fund to support the Board's operations and sets penalties for noncompliance.

Senate Bill 601 proposes an amendment to the Pharmacy Act in Pennsylvania. The bill would permit ivermectin, when intended for human use, to be sold and purchased as an over-the-counter medication. This change would allow individuals to obtain ivermectin without a prescription or consultation with a healthcare professional.